INS and Hypoglycemia: The increased frequency of DKA observed in this subpopulation can be explained by the renal and pancreatic effects of SGLT2-inhibitors that are emphasized in patients in therapy with insulin, since to minimize the risk of hypoglycaemia it is necessary to further decrease the insulin dose.